Table 1.
Baseline demographic and medical characteristics of women who completed questionnaires at baseline and follow-up (n=1121). N (%)
| HIV+ | HIV− | P-value1 | Missing | p-value | |
|---|---|---|---|---|---|
| N=773 | N=348 | ||||
| Age at interview (years) | |||||
| <30 | 44 (5.7) | 63 (18.1) | <0.0001 | ||
| 30-39 | 198 (25.6) | 113 (32.5) | |||
| 40-49 | 332 (43.0) | 111 (31.9) | |||
| 50+ | 199 (25.7) | 61 (17.5) | |||
| Ethnicity | |||||
| Non-Hispanic African American |
497 (64.3) | 219 (62.9) | 0.01 | ||
| Hispanic | 139 (18.0) | 84 (24.2) | |||
| Non-Hispanic White | 110 (14.2) | 30 (8.6) | |||
| Other | 27 (3.5) | 15 (4.3) | |||
| Average annual household income (n=1062) |
|||||
| <=$6,000 | 121 (16.4) | 79 (24.3) | 0.02 | ||
| $6,001-$12,000 | 216 (29.3) | 80 (24.6) | |||
| $12,001-$18,000 | 105 (14.3) | 41 (12.6) | |||
| $18,001+ | 295 (40.1) | 125 (38.5) | |||
| Education level (n=1119) | |||||
| Less than high school | 249 (32.3) | 116 (33.4) | 0.26 | ||
| Completed high school | 234 (30.3) | 118 (34.0) | |||
| Some College/College degree |
289 (37.4) | 113 (32.6) | |||
| Site/Location | |||||
| Bronx | 116 (15.0) | 65 (18.7) | 0.0009 | ||
| Brooklyn | 215 (27.8) | 73 (21.0) | |||
| Washington DC | 124 (16.0) | 47 (13.5) | |||
| Los Angeles | 84 (10.9) | 62 (17.8) | |||
| San Francisco | 110 (14.3) | 60 (17.2) | |||
| Chicago | 124 (16.0) | 41 (11.8) | |||
| Alcohol use | |||||
| Abstainer | 462 (59.8) | 165 (47.4) | <0.0001 | ||
| Light (<3 drinks/wk) | 225 (29.1) | 111 (31.9) | |||
| Moderate/Heavy (3+ drinks/wk) |
86 (11.1) | 72 (20.7) | |||
| Current Smoker | 337 (43.6) | 171 (49.1) | 0.08 | ||
| Injection drug use status | |||||
| Current user | 13 (1.7) | 7 (2.0) | 0.003 | ||
| Former user | 187 (24.2) | 53 (15.2) | |||
| Never | 573 (74.1) | 288 (82.8) | |||
| Non-Injection drug use status |
|||||
| Current user | 177 (22.9) | 116 (33.3) | 0.0002 | ||
| Former user | 395 (51.1) | 171 (47.1) | |||
| Never | 201 (26.0) | 61 (17.5) | |||
| English WRAT2 score (number of words pronounced correctly) (n=898) |
|||||
| Mean | 28.9 | 28.7 | 0.803 | ||
| Median | 31.0 | 29.0 | 0.564 | ||
| Range | 3 - 42 | 8 - 42 | |||
| Lifetime nadir CD4 lymphocyte count (cells/cmm) (n=773) |
|||||
| <200 | 355 (45.9) | ||||
| 200-500 | 357 (46.2) | ||||
| >500 | 61 (7.9) | ||||
| CD4 lymphocyte count (cells/cmm) at visit (n=773) |
|||||
| <200 | 101 (13.1) | ||||
| 200-500 | 303 (39.2) | ||||
| >500 | 369 (47.7) |
1
P-value obtained by using the chi-square test unless otherwise specified.
2
Wide Range Achievement Test
3
P-value obtained by using the t-test for means.
4
P-value obtained using the Wilcoxon rank-sum test.
P-value comparing missing to all those who completed entire survey.